News

Hims & Hers Health to offer $450M convertible senior notes
Hims & Hers Health (NYSE:HIMS) plans to offer $450M aggregate principal amount of convertible senior notes due 2030 in a private offering. The notes will accrue interest payable semi-annually in ...
Why Hims & Hers turned to the autonomous vehicle industry to find an AI-savvy CTO
Hims & Hers, the telehealth and wellness company, has hired a veteran of the autonomous vehicle industry as its next chief ...
How much a $1,000 investment in Hims & Hers at its IPO would be worth now
Hims & Hers stock has risen by 20% after announcing a partnership to sell the popular weight-loss drug Wegovy.
Hims & Hers: The Road To Blue Chip Status
Hims & Hers achieved 136% YoY subscriber growth and unveiled ambitious 2030 goals. Discover how precision medicine drives ...
24/7 Wall St.1d
Hims & Hers Shows It's More Than Just GLP-1 Drugs
Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after ...
What’s Next For HIMS Stock After A Solid Q1?
The company reported adjusted earnings per share of $0.28 on revenue of $586 million – a significant rise compared to last ...
Hims & Hers Soars Again--Explosive Growth Meets Lofty Expectations
Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...
Hims & Hers shares fall on convertible notes offering
The decline in Hims & Hers’ stock price comes as the market reacts to the potential dilution of shares resulting from the ...
24/7 Wall St. on MSN2d
Hims & Hers (NYSE: HIMS) Earnings Are In (Live Coverage)
Hims & Hers Health (NYSE: HIMS) will report its Q1 2025 financial results today, after the market closes with a conference ...